GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, APP, BCL2, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DRD1, EGFR, ESR1, ESRRA, FABP3, GSK3B, HSD11B2, HSD17B2, HTR5A, IDO1, IGF1R, INSR, MMP2, MMP9, PPARA, PTGS2, SRC, TEK, TYR |
11.373 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, ALPL, APP, BCL2, CA2, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DRD1, EGFR, ESR1, ESRRA, FABP3, FABP4, FLT3, GSK3B, HSD11B2, HSD17B2, HSPA1A, HTR5A, IDO1, IGF1R, INSR, KDR, MMP2, PPARA, PTGS2, SMAD3, SRC, TEK, TYR |
10.7581 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, AKR1B1, APP, BCL2, CDC25B, CDK6, CSNK2A1, CYP1B1, EGFR, ESR1, ESRRA, F3, FABP3, FLT3, HSPA1A, HTR1A, HTR2B, IDO1, IGF1R, INSR, KDR, MMP12, MMP2, MMP9, NUAK1, PTGS2, SMAD3, SRC, TEK, XDH |
10.7581 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, AKR1B1, APP, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, EGFR, F3, FLT3, GPR35, GSK3B, HSPA1A, HTR2B, HTR6, INSR, KDR, MET, MMP12, MMP9, PTGS2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
10.7581 |
[BP] GO:0042221 |
response to chemical
|
AKR1B1, ALPL, APP, BCL2, CA2, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DRD1, EGFR, ESR1, ESRRA, FABP3, FABP4, FLT3, GSK3B, HSD11B2, HSD17B2, HSPA1A, HTR2B, HTR5A, IDO1, IGF1R, INSR, KDR, MMP2, MMP9, PPARA, PTGS2, SMAD3, SRC, TEK, TOP1, TYR |
10.7581 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, AKR1B1, APP, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, EGFR, F3, FLT3, GPR35, GSK3B, HSPA1A, HTR2B, HTR6, INSR, KDR, MET, MMP12, MMP9, PTGS2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
10.7581 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APP, BACE1, BCL2, CA1, CA12, CA2, CA4, CA6, CA7, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DRD1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GBA2, GSK3B, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, HTR1A, HTR2B, IDO1, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PPARA, PTGS2, PTPN1, SMAD3, SRC, TBXAS1, TEK, TNKS, TNKS2, TOP1, TYR, XDH |
9.9918 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, ADORA1, AKR1B1, APP, BCL2, CA12, CA2, CA7, CDK6, CYP19A1, CYP1A1, CYP1B1, DHFR, DRD1, EGFR, ESR1, F3, FABP3, FABP4, FLT3, GPR35, GSK3B, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, HTR1A, HTR2B, HTR7, INSR, KDR, MET, PPARA, PTGS2, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
9.87076 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, ALPL, APP, BCL2, CA2, CSNK2A1, CYP1A2, DRD1, EGFR, ESR1, ESRRA, FABP3, FLT3, GSK3B, HSD11B2, HTR5A, IGF1R, INSR, MMP2, PPARA, PTGS2, SMAD3, SRC, TEK |
9.87076 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, APP, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, FABP3, FABP4, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, MET, PPARA, PTGS2, TBXAS1 |
8.88996 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ALPL, APP, BCL2, CA2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DRD1, EGFR, ESR1, ESRRA, FLT3, HSD11B2, HTR5A, PTGS2, SRC, TEK, TYR |
8.61951 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, AKR1B1, APP, BCL2, CSNK2A1, CYP1B1, EGFR, F3, FLT3, GPR35, GSK3B, HSPA1A, HTR2B, HTR6, INSR, KDR, MET, MMP12, MMP9, PTGS2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
8.45719 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, AKR1B1, APP, BACE1, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DUSP3, EGFR, ESR1, ESR2, F3, FLT3, GPR35, GSK3B, HSPA1A, HTR1A, HTR2B, HTR6, IGF1R, INSR, KDR, MET, MMP12, MMP9, NUAK1, PTGS2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
8.34428 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, AKR1B1, APP, BCL2, CA2, CA7, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, GPR35, GSK3B, HSPA1A, HTR1A, HTR2B, HTR6, IDO1, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
8.22405 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, AKR1B1, APP, BACE1, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DUSP3, EGFR, ESR1, ESR2, F3, FLT3, GPR35, GSK3B, HSPA1A, HTR1A, HTR2B, HTR6, IGF1R, INSR, KDR, MET, MMP12, MMP9, NUAK1, PTGS2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
8.22405 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, APP, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
8.07172 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, AKR1B1, APP, BCL2, CSNK2A1, CYP1B1, EGFR, ESRRA, F3, FABP4, FLT3, GPR35, GSK3B, HSPA1A, HTR2B, HTR6, IDO1, INSR, KDR, MET, MMP12, MMP2, MMP9, PTGS2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
7.93577 |
[BP] GO:0033993 |
response to lipid
|
ALPL, BCL2, CA2, CDK6, CSNK2A1, CYP1A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, FLT3, HSD11B2, HSD17B2, HTR5A, IDO1, PTGS2, SRC, TYR |
7.84768 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, ALPL, BCL2, CA2, CSNK2A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, FLT3, HSD11B2, HTR5A, INSR, PPARA, PTGS2, SRC, TEK |
7.54217 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADORA1, AKR1B1, APP, BCL2, CA2, CA7, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DHFR, DRD1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GPR35, GSK3B, HSPA1A, HTR1A, HTR2B, HTR6, IDO1, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
7.54217 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, APP, BCL2, CYP19A1, CYP1A2, CYP1B1, DRD1, DUSP3, EGFR, ESR1, ESRRB, F3, FABP4, HSD11B2, HSD17B2, HTR1A, HTR2B, HTR7, IDO1, IGF1R, INSR, MET, MMP1, MMP12, MMP2, MMP9, PPARA, PTGS2, SMAD3, SRC, TEK, TNKS2, TOP1, TYR |
7.47211 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, ALOX5, AOX1, APP, CA1, CA12, CA2, CA4, CA6, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, FABP3, FUT7, GBA2, HSPA1A, HTR2B, IDO1, PPARA, PTGS2, TBXAS1, TYR, XDH |
7.41507 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APP, BACE1, BCL2, CA1, CA12, CA2, CA4, CA6, CA7, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DRD1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, FUT7, GBA2, GSK3B, HSD17B1, HSD17B2, HSPA1A, HTR1A, HTR2B, IDO1, IGF1R, INSR, KDR, MET, MMP1, MMP2, NUAK1, PPARA, PTGS2, PTPN1, SMAD3, SRC, TBXAS1, TEK, TNKS, TNKS2, TOP1, TYR, XDH |
7.38617 |
[BP] GO:0080134 |
regulation of response to stress
|
ADORA1, APP, CDK6, CYP19A1, DHFR, DUSP3, EGFR, ESR1, F3, FABP4, GSK3B, HSPA1A, IDO1, IGF1R, MET, MMP12, MMP2, NUAK1, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
7.38617 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ADORA1, AKR1B1, APP, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1B1, DHFR, DRD1, DUSP3, EGFR, ESR1, ESR2, ESRRA, F3, FABP4, FLT3, GPR35, GSK3B, HSPA1A, HTR2B, HTR6, IDO1, IGF1R, INSR, KDR, MET, MMP12, MMP2, MMP9, NUAK1, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
7.38617 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA6, CA7, DHFR |
7.34182 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, APP, BCL2, CDK6, CYP19A1, CYP1B1, DRD1, EGFR, F3, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK |
7.0061 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, ALPL, AOX1, APP, BACE1, BCL2, CDC25B, CDK6, CSNK2A1, CYP1A1, CYP1A2, DHFR, DRD1, DUSP3, EGFR, ESR1, F3, FLT3, FUT7, GBA2, GSK3B, HSPA1A, HTR1A, HTR2B, IDO1, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, TOP1, TYR, XDH |
6.79598 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA6, CA7 |
6.74472 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APP, BACE1, BCL2, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DRD1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GBA2, GSK3B, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, HTR2B, IDO1, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PPARA, PTGS2, PTPN1, SMAD3, SRC, TBXAS1, TEK, TNKS, TNKS2, TOP1, TYR, XDH |
6.72893 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, AKR1B1, APP, BCL2, CYP1B1, EGFR, F3, FLT3, GPR35, HSPA1A, HTR2B, HTR6, INSR, KDR, MET, PTGS2, PTPN1, SRC, TEK, XDH |
6.6823 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA1, ADORA3, AKR1B1, ALPL, APP, BCL2, CA2, CA6, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DRD1, EGFR, ESR1, ESRRA, F3, FABP3, FABP4, FLT3, GSK3B, HSD11B2, HSD17B2, HSPA1A, HTR1A, HTR2B, HTR5A, IDO1, IGF1R, INSR, KDR, MMP12, MMP2, MMP9, NUAK1, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TOP1, TYR |
6.67891 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APP, BACE1, BCL2, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DRD1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GBA2, GSK3B, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, HTR1A, HTR2B, IDO1, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PPARA, PTGS2, PTPN1, SMAD3, SRC, TBXAS1, TEK, TNKS, TNKS2, TOP1, TYR, XDH |
6.64898 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, APP, BCL2, CYP19A1, CYP1B1, DRD1, EGFR, F3, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK |
6.64678 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, BCL2, CDC25B, CDK6, CSNK2A1, EGFR, ESR1, F3, FLT3, HTR1A, HTR2B, IGF1R, INSR, KDR, MMP12, MMP2, MMP9, PTGS2, TEK |
6.58676 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, APP, BCL2, CDK6, CYP19A1, CYP1B1, DRD1, EGFR, F3, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK |
6.54933 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, AKR1B1, ALPL, APP, BCL2, CA2, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DRD1, DUSP3, EGFR, ESR1, ESRRA, ESRRB, FLT3, GBA2, GSK3B, HSD11B1, HSD17B2, HTR5A, INSR, KDR, MMP9, PPARA, PTGS2, SMAD3, SRC, TEK, TYR |
6.54933 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, APP, BCL2, CDK6, CYP19A1, CYP1B1, DRD1, EGFR, F3, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK |
6.54481 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, GSK3B, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IDO1, PTGS2, TBXAS1, TYR, XDH |
6.53861 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, BCL2, CYP1A1, CYP1A2, CYP1B1, TYR |
6.40492 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALPL, APP, BCL2, CDC25B, CDK6, CSNK2A1, DHFR, DRD1, DUSP3, EGFR, FLT3, GSK3B, HSPA1A, HTR2B, IGF1R, INSR, KDR, MET, NUAK1, PTGS2, PTPN1, SRC, TEK, TNKS, TOP1, XDH |
6.37525 |
[BP] GO:0030335 |
positive regulation of cell migration
|
APP, BCL2, DRD1, EGFR, F3, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK |
6.37463 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, AKR1B1, APP, BCL2, CSNK2A1, CYP1B1, DUSP3, EGFR, ESR1, F3, FLT3, GPR35, HSPA1A, HTR2B, HTR6, IGF1R, INSR, KDR, MET, MMP9, NUAK1, PTGS2, PTPN1, SRC, TEK, XDH |
6.37179 |
[BP] GO:0006468 |
protein phosphorylation
|
APP, BCL2, CDC25B, CDK6, CSNK2A1, DRD1, EGFR, FLT3, GSK3B, HTR2B, IGF1R, INSR, KDR, MET, NUAK1, SRC, TEK, TNKS, TOP1 |
6.27991 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA1, ADORA3, APP, BCL2, CA2, CA7, CDK6, CSNK2A1, CYP19A1, CYP1B1, DRD1, EGFR, F3, GPR35, GSK3B, HSPA1A, HTR1A, HTR2B, IGF1R, INSR, KDR, MET, MMP12, MMP9, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK |
6.22271 |
[BP] GO:2000147 |
positive regulation of cell motility
|
APP, BCL2, DRD1, EGFR, F3, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK |
6.21759 |
[BP] GO:0048513 |
animal organ development
|
ACHE, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, EGFR, ESR1, ESRRA, ESRRB, FLT3, HSD11B1, HSD17B2, INSR, KDR, PPARA, SMAD3, SRC, TEK, TYR |
6.20653 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, BCL2, CSNK2A1, EGFR, GSK3B, HSPA1A, HTR2B, IDO1, IGF1R, KDR, MET, MMP9, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK |
6.20653 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
6.14477 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
APP, BCL2, DRD1, EGFR, F3, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK |
6.09241 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APP, DHFR, DRD1, EGFR, FABP3, FLT3, GSK3B, HSD11B2, IGF1R, INSR, MMP2, PPARA, PTGS2, SRC, TEK, TYR |
6.03312 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALPL, APP, BCL2, CDC25B, CDK6, CSNK2A1, DHFR, DRD1, DUSP3, EGFR, FLT3, GSK3B, HSPA1A, HTR2B, IGF1R, INSR, KDR, MET, NUAK1, PTGS2, PTPN1, SRC, TEK, TNKS, TOP1, XDH |
6.03312 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, BCL2, CSNK2A1, EGFR, GSK3B, HSPA1A, HTR2B, IDO1, IGF1R, KDR, MET, MMP9, PTGS2, PTPN1, SMAD3, SRC, TEK |
6.02609 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, ALPL, APP, BCL2, CDK6, CYP1A1, CYP1A2, CYP1B1, DRD1, EGFR, ESR1, FABP4, FLT3, GSK3B, HSPA1A, IGF1R, INSR, KDR, MMP2, MMP9, PTGS2, SMAD3, SRC |
6.00523 |
[BP] GO:0040017 |
positive regulation of locomotion
|
APP, BCL2, DRD1, EGFR, F3, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK |
5.94456 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, AKR1B1, ALPL, APP, BCL2, CA2, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DRD1, DUSP3, EGFR, ESR1, ESRRA, ESRRB, FABP4, FLT3, FUT7, GBA2, GSK3B, HSD11B1, HSD17B2, HTR2B, HTR5A, INSR, KDR, MET, MMP2, MMP9, PPARA, PTGS2, SMAD3, SRC, TEK, TNKS2, TYR |
5.94456 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, BCL2, CSNK2A1, CYP1B1, EGFR, ESR1, F3, FLT3, GSK3B, HSPA1A, HTR2B, IDO1, IGF1R, KDR, MET, MMP9, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
5.94456 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, BCL2, CSNK2A1, CYP1B1, EGFR, ESR1, F3, FLT3, GSK3B, HSPA1A, HTR2B, IDO1, IGF1R, KDR, MET, MMP9, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
5.85202 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA3, APP, BCL2, CDC25B, CSNK2A1, DHFR, DRD1, DUSP3, EGFR, ESR1, F3, FABP4, FLT3, GSK3B, HSPA1A, HTR2B, IGF1R, INSR, MMP9, NUAK1, PTGS2, PTPN1, SMAD3, SRC, TEK, TNKS, XDH |
5.69731 |
[BP] GO:0003018 |
None
|
ADORA1, DRD1, EGFR, HTR1A, HTR2B, HTR7, PTGS2, SRC, TEK |
5.6719 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, APP, DHFR, DRD1, EGFR, FABP3, FLT3, GSK3B, HSD11B2, IGF1R, INSR, MMP2, PPARA, PTGS2, SRC, TEK, TYR |
5.6102 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, APP, BCL2, CDC25B, DRD1, DUSP3, EGFR, ESRRB, FABP3, FABP4, FLT3, HTR2B, IGF1R, INSR, KDR, MMP9, NUAK1, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
5.48664 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, APP, BCL2, CDC25B, DRD1, DUSP3, EGFR, ESRRB, FABP3, FABP4, FLT3, HTR2B, IGF1R, INSR, KDR, MMP9, NUAK1, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
5.43059 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, BCL2, CSNK2A1, EGFR, GSK3B, HSPA1A, HTR2B, IDO1, IGF1R, KDR, MMP9, PTGS2, PTPN1, SMAD3, SRC, TEK |
5.37987 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, ALPL, APP, BCL2, CDK6, CYP1A1, CYP1B1, DRD1, EGFR, ESR1, FABP4, FLT3, GSK3B, IGF1R, INSR, KDR, MMP2, PTGS2, SMAD3, SRC |
5.37138 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, BCL2, CDK6, CYP19A1, DRD1, DUSP3, EGFR, ESR1, ESR2, GSK3B, HSPA1A, IGF1R, MET, MMP12, MMP9, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
5.35635 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, AKR1B1, APP, BCL2, CSNK2A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, F3, FLT3, GPR35, GSK3B, HSPA1A, HTR2B, HTR6, IGF1R, INSR, KDR, MET, MMP12, MMP9, NUAK1, PTGS2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
5.3472 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, APP, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, EGFR, FABP4, KDR, MMP9, PTGS2, SRC |
5.34587 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, APP, BCL2, CDC25B, DRD1, EGFR, ESRRB, FABP3, FLT3, HTR2B, INSR, KDR, MMP9, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
5.33111 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, APP, BCL2, CDC25B, DRD1, EGFR, ESRRB, FABP3, FLT3, HTR2B, INSR, KDR, MMP9, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
5.33111 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, APP, BCL2, CDC25B, CSNK2A1, DHFR, DRD1, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, GSK3B, HSPA1A, HTR2B, IGF1R, INSR, KDR, MET, MMP12, MMP9, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
5.29955 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, BCL2, CSNK2A1, CYP1B1, EGFR, ESR1, F3, FLT3, GSK3B, HSPA1A, HTR2B, IDO1, IGF1R, KDR, MMP9, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
5.2986 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, APP, BCL2, CDC25B, CSNK2A1, DRD1, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GSK3B, HSPA1A, HTR2B, IGF1R, INSR, KDR, MET, MMP12, MMP9, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
5.2986 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, BCL2, CA2, CA7, CDK6, DRD1, EGFR, HTR2B, KDR, PTGS2, SRC, TNKS, TNKS2 |
5.24014 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, AKR1B1, APP, BCL2, CA2, CYP1A1, DRD1, EGFR, HSD11B2, HSPA1A, HTR2B, MMP2, PPARA, PTGS2, SMAD3, SRC, TEK, TYR |
5.21307 |
[BP] GO:0007210 |
None
|
HTR1A, HTR2B, HTR5A, HTR6, HTR7 |
5.19514 |
[BP] GO:0098664 |
None
|
HTR1A, HTR2B, HTR5A, HTR6, HTR7 |
5.19514 |
[BP] GO:0065009 |
regulation of molecular function
|
ADORA1, ADORA3, APP, BCL2, CDC25B, CSNK2A1, CYP1B1, DHFR, DRD1, DUSP3, EGFR, ESR1, ESR2, F3, FABP4, FLT3, GPR35, GSK3B, HSPA1A, HTR2B, IGF1R, INSR, MET, MMP9, NUAK1, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TNKS, XDH |
5.12938 |
[BP] GO:0016310 |
phosphorylation
|
APP, BCL2, CDC25B, CDK6, CSNK2A1, DRD1, EGFR, FLT3, GSK3B, HTR2B, IGF1R, INSR, KDR, MET, NUAK1, SRC, TEK, TNKS, TOP1 |
5.09055 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, BCL2, DRD1, DUSP3, EGFR, ESR1, ESR2, GPR35, GSK3B, HSPA1A, IGF1R, MET, MMP12, MMP9, PTGS2, PTPN1, SMAD3, SRC, XDH |
5.08857 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, BCL2, DRD1, DUSP3, EGFR, ESR1, ESR2, GPR35, GSK3B, HSPA1A, IGF1R, MET, MMP12, MMP9, PTGS2, PTPN1, SMAD3, SRC, XDH |
5.07063 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, APP, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1B1, DHFR, DRD1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GPR35, GSK3B, HSPA1A, HTR2B, IDO1, IGF1R, KDR, MET, MMP12, MMP9, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
5.05299 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, APP, BCL2, CYP19A1, CYP1A1, CYP1B1, DHFR, DRD1, GBA2, HTR1A, TYR |
5.01885 |
[BP] GO:0001666 |
response to hypoxia
|
ADORA1, BCL2, CYP1A1, HSD11B2, MMP2, PPARA, PTGS2, SMAD3, SRC, TEK |
5.00974 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, APP, BCL2, CDC25B, DRD1, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, GSK3B, HSPA1A, HTR2B, IGF1R, INSR, KDR, MET, MMP12, MMP9, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
5.0023 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, AKR1B1, CYP19A1, CYP1A1, CYP1B1, EGFR, ESR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HTR1A |
4.98222 |
[BP] GO:0046777 |
protein autophosphorylation
|
CSNK2A1, EGFR, FLT3, GSK3B, IGF1R, INSR, KDR, SRC, TEK |
4.97842 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, APP, BCL2, CDC25B, CSNK2A1, DRD1, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GSK3B, HSPA1A, HTR2B, IGF1R, INSR, KDR, MET, MMP12, MMP9, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
4.96468 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
ADORA1, BCL2, CYP1A1, HSD11B2, MMP2, PPARA, PTGS2, SMAD3, SRC, TEK |
4.92145 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, APP, FABP3, GSK3B, HSD11B2, IGF1R, INSR, PPARA, PTGS2, SRC, TEK |
4.84428 |
[BP] GO:0003013 |
None
|
ADORA1, DRD1, EGFR, HTR1A, HTR2B, HTR7, PTGS2, SRC, TEK |
4.83432 |
[BP] GO:0042493 |
response to drug
|
AKR1B1, BCL2, CDK6, CYP1A1, CYP1B1, DHFR, DRD1, EGFR, FABP3, HSD11B2, HTR2B, KDR, PTGS2, SRC, TOP1 |
4.797 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, APP, BCL2, CDC25B, DRD1, DUSP3, EGFR, ESRRB, FABP4, FLT3, HTR2B, IGF1R, INSR, KDR, MMP9, PPARA, PTGS2, PTPN1, SRC, TEK, XDH |
4.72818 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
4.68734 |
[BP] GO:0001952 |
regulation of cell-matrix adhesion
|
BCL2, CDK6, GSK3B, KDR, SMAD3, SRC, TEK |
4.652 |
[BP] GO:0070482 |
response to oxygen levels
|
ADORA1, BCL2, CYP1A1, HSD11B2, MMP2, PPARA, PTGS2, SMAD3, SRC, TEK |
4.5987 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, AOX1, BACE1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, FUT7, GBA2, GSK3B, HSPA1A, IDO1, MMP1, MMP12, MMP2, MMP9, SRC, XDH |
4.58879 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2 |
4.52448 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, CYP19A1, DRD1, EGFR, ESR1, F3, FABP4, IDO1, KDR, MET, MMP12, PPARA, PTGS2, SMAD3, TEK |
4.47152 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, AKR1B1, APP, BCL2, CA1, CA2, CDK6, CSNK2A1, CYP1B1, DRD1, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPR35, GSK3B, HTR1A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, MMP2, MMP9, NUAK1, PPARA, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2 |
4.45445 |
[BP] GO:0031347 |
regulation of defense response
|
ADORA1, CYP19A1, EGFR, ESR1, FABP4, HSPA1A, IDO1, MMP12, MMP2, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK |
4.45414 |
[BP] GO:0007198 |
None
|
HTR1A, HTR5A, HTR7 |
4.45414 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.45414 |
[BP] GO:2000377 |
regulation of reactive oxygen species metabolic process
|
BCL2, CYP1B1, DHFR, EGFR, INSR, PTGS2, SMAD3, XDH |
4.3905 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ADORA1, APP, BCL2, CDC25B, DHFR, EGFR, ESR1, ESR2, F3, FLT3, GSK3B, HSPA1A, HTR2B, INSR, MET, MMP9, PTPN1, SMAD3, SRC, TEK, TNKS, XDH |
4.34719 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ADORA1, APP, BCL2, CDC25B, CSNK2A1, EGFR, ESR1, F3, FLT3, GSK3B, HSPA1A, HTR2B, INSR, KDR, MMP9, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
4.24698 |
[BP] GO:0097756 |
None
|
ADORA1, HTR1A, HTR2B, HTR7, PTGS2 |
4.24577 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADORA1, APP, CA2, CA7, DRD1, EGFR, PTGS2 |
4.22685 |
[BP] GO:0048878 |
chemical homeostasis
|
AKR1B1, APP, BCL2, CA12, CA2, CA7, DRD1, EGFR, ESR1, FABP3, FABP4, GPR35, HTR2B, INSR, MET, SMAD3 |
4.22579 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, BCL2, CYP1A1, DHFR, EGFR, PPARA, SMAD3 |
4.22579 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, HTR2B, PPARA, PTGS2, SRC, TEK |
4.19102 |
[BP] GO:0097746 |
None
|
ADORA1, DRD1, EGFR, HTR1A, HTR2B, HTR7, PTGS2 |
4.17329 |
[BP] GO:0035296 |
None
|
ADORA1, DRD1, EGFR, HTR1A, HTR2B, HTR7, PTGS2 |
4.17329 |
[BP] GO:0022414 |
reproductive process
|
AKR1B1, ALPL, APP, BCL2, CDC25B, CYP19A1, CYP1A1, DRD1, EGFR, ESR1, ESRRB, HSD11B2, HSD17B2, IDO1, INSR, MMP2, MMP9, PTGS2, SRC |
4.15377 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, AKR1B1, APP, BCL2, CA12, CA2, CA7, DRD1, EGFR, ESR1, FABP3, FABP4, FLT3, GPR35, HTR2B, INSR, MET, SMAD3, SRC |
4.13731 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, ALPL, APP, BCL2, CA2, CDK6, CYP1A1, CYP1A2, CYP1B1, DHFR, DRD1, EGFR, ESR1, FABP4, FLT3, GSK3B, HSPA1A, IGF1R, INSR, KDR, MMP2, MMP9, NUAK1, PTGS2, PTPN1, SMAD3, SRC |
4.13466 |
[BP] GO:0001505 |
regulation of neurotransmitter levels
|
ACHE, CYP1B1, DHFR, DRD1, EGFR, HTR1A, INSR, PTGS2, SMAD3 |
4.13466 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX5, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, FABP3, FABP4, FUT7, GBA2, MET, PPARA, PTGS2, TBXAS1 |
4.13466 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
4.1296 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
4.0798 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, FLT3, HTR2B, SRC, TEK |
4.07375 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, APP, BCL2, CDC25B, DRD1, DUSP3, EGFR, FABP4, FLT3, HTR2B, IGF1R, INSR, KDR, MMP9, PTGS2, PTPN1, SRC, TEK, XDH |
4.06642 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, AOX1, CYP1A1, CYP1A2, CYP1B1, DHFR, DRD1, EGFR, HSPA1A, IDO1 |
4.04873 |
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
ADORA1, APP, BCL2, CDC25B, EGFR, ESR1, F3, FLT3, GSK3B, HSPA1A, HTR2B, INSR, KDR, MMP9, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
4.03771 |
[BP] GO:0050880 |
None
|
ADORA1, DRD1, EGFR, HTR1A, HTR2B, HTR7, PTGS2 |
4.02448 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, APP, BCL2, CDC25B, EGFR, ESRRB, FLT3, HTR2B, INSR, KDR, MMP9, PTGS2, PTPN1, SRC, TEK, XDH |
4.01043 |
[BP] GO:0035150 |
None
|
ADORA1, DRD1, EGFR, HTR1A, HTR2B, HTR7, PTGS2 |
4.00794 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, APP, BCL2, CA2, CDK6, CYP1B1, EGFR, ESR1, ESRRA, ESRRB, F3, GPR35, GSK3B, HSPA1A, HTR2B, IDO1, INSR, KDR, MET, MMP12, MMP9, PTGS2, SMAD3, SRC, TEK, TNKS2, XDH |
4.00161 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, AKR1B1, APP, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1B1, DHFR, DRD1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GPR35, GSK3B, HSPA1A, HTR2B, IDO1, IGF1R, KDR, MET, MMP12, MMP9, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
4.00161 |
[BP] GO:0001954 |
positive regulation of cell-matrix adhesion
|
CDK6, GSK3B, KDR, SMAD3, TEK |
3.99822 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, APP, CDK6, CYP1B1, DRD1, EGFR, ESR1, GSK3B, IGF1R, INSR, MMP2, MMP9, PTGS2, SRC |
3.9907 |
[BP] GO:0032268 |
regulation of cellular protein metabolic process
|
ADORA1, APP, BCL2, CDC25B, CSNK2A1, DHFR, DRD1, DUSP3, EGFR, ESR1, F3, FABP4, FLT3, GSK3B, HSPA1A, HTR2B, IGF1R, INSR, KDR, MMP9, NUAK1, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
3.9907 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
ALPL, APP, CYP1A1, CYP1B1, DRD1, EGFR, ESR1, FLT3, PTGS2, SRC |
3.9784 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ADORA1, APP, BCL2, CA2, CA7, CYP19A1, DRD1, EGFR, GPR35, GSK3B, HSPA1A, HTR1A, HTR2B, INSR, MMP12, MMP9, PPARA, PTGS2, PTPN1, SMAD3, SRC |
3.97536 |
[BP] GO:0080135 |
regulation of cellular response to stress
|
APP, CDK6, DHFR, DUSP3, EGFR, GSK3B, HSPA1A, IGF1R, MET, NUAK1, PTGS2, PTPN1, XDH |
3.946 |
[BP] GO:0038083 |
peptidyl-tyrosine autophosphorylation
|
EGFR, IGF1R, INSR, KDR, SRC |
3.9234 |
[BP] GO:0043085 |
positive regulation of catalytic activity
|
ADORA1, APP, BCL2, CDC25B, DHFR, EGFR, ESR1, F3, FLT3, GSK3B, HSPA1A, HTR2B, INSR, PTPN1, SMAD3, SRC, TEK, TNKS, XDH |
3.91605 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, BCL2, CA2, CA7, DRD1, HTR2B, KDR, SRC |
3.82591 |
[BP] GO:0048511 |
rhythmic process
|
BCL2, CSNK2A1, EGFR, ESR1, GSK3B, HTR7, PPARA, SRC, TOP1 |
3.81367 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, APP, CSNK2A1, CYP1B1, DUSP3, ESR1, FABP4, GPR35, GSK3B, IGF1R, MET, MMP9, PPARA, PTGS2, PTPN1, SRC, TNKS |
3.80549 |
[BP] GO:0031399 |
regulation of protein modification process
|
ADORA1, APP, BCL2, CDC25B, DRD1, DUSP3, EGFR, FABP4, FLT3, HSPA1A, HTR2B, IGF1R, INSR, KDR, MMP9, NUAK1, PTGS2, PTPN1, SRC, TEK, XDH |
3.73151 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
AKR1B1, APP, DRD1, EGFR, ESR1, FLT3, GSK3B, IGF1R, INSR, MMP2, PTGS2, SMAD3, SRC |
3.73151 |
[BP] GO:2001243 |
negative regulation of intrinsic apoptotic signaling pathway
|
BCL2, HSPA1A, MMP9, PTGS2, PTPN1, SRC |
3.72007 |
[BP] GO:0048545 |
response to steroid hormone
|
ALPL, BCL2, CA2, EGFR, FLT3, HSD11B2, PTGS2, SRC |
3.68542 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, PTGS2, TBXAS1 |
3.67169 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, PTGS2, TBXAS1 |
3.6628 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.65421 |
[BP] GO:0050727 |
regulation of inflammatory response
|
ADORA1, CYP19A1, EGFR, ESR1, FABP4, IDO1, PPARA, PTGS2, SMAD3, TEK |
3.64957 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, APP, BACE1, CA2, CA7, DRD1, EGFR, PTGS2 |
3.64957 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, APP, BACE1, CA2, CA7, DRD1, EGFR, PTGS2 |
3.64957 |
[BP] GO:0031960 |
response to corticosteroid
|
ALPL, BCL2, EGFR, FLT3, HSD11B2, PTGS2, SRC |
3.64957 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, APP, BCL2, CDC25B, EGFR, FLT3, HTR2B, INSR, KDR, MMP9, PTGS2, PTPN1, SRC, TEK, XDH |
3.62024 |
[BP] GO:0071417 |
cellular response to organonitrogen compound
|
AKR1B1, APP, DRD1, EGFR, GSK3B, IGF1R, INSR, MMP2, PTGS2, SRC |
3.59285 |
[BP] GO:0019538 |
protein metabolic process
|
ACHE, ALPL, APP, BACE1, BCL2, CDC25B, CDK6, CSNK2A1, DRD1, DUSP3, EGFR, ESR1, F3, FLT3, FUT7, GSK3B, HTR2B, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PPARA, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, TOP1 |
3.5499 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
EGFR, FLT3, IGF1R, INSR, KDR, MET, MMP2, MMP9, PTPN1, SRC, TEK |
3.54251 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADORA1, APP, DUSP3, EGFR, FLT3, HTR2B, IGF1R, INSR, KDR, PTPN1, SRC, TEK, XDH |
3.53986 |
[BP] GO:0051050 |
positive regulation of transport
|
ACHE, ADORA1, APP, BCL2, CA2, CYP19A1, DRD1, EGFR, GSK3B, HTR2B, INSR, MMP12, PTGS2, SMAD3, SRC |
3.53914 |
[BP] GO:0007166 |
cell surface receptor signaling pathway
|
ADORA1, ADORA3, APP, BCL2, CA1, CSNK2A1, EGFR, F3, FLT3, GPR35, GSK3B, IGF1R, INSR, KDR, MET, MMP2, MMP9, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2 |
3.53914 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, PTGS2, TBXAS1 |
3.53543 |
[BP] GO:0010638 |
positive regulation of organelle organization
|
BCL2, GSK3B, HSPA1A, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK, TNKS, TNKS2 |
3.47945 |
[BP] GO:0010038 |
response to metal ion
|
APP, BCL2, CA2, CYP1A1, CYP1A2, EGFR, FABP4, MMP9, PTGS2 |
3.4755 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, APP, EGFR, FLT3, HTR2B, INSR, KDR, PTPN1, SRC, TEK, XDH |
3.46933 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, DHFR, EGFR, FABP3, HSD17B2, KDR, MMP2, PTGS2, SRC |
3.45288 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
BCL2, DUSP3, ESR1, HSPA1A, IGF1R, MET, MMP9, PTGS2, PTPN1, SRC, XDH |
3.43116 |
[BP] GO:0051246 |
regulation of protein metabolic process
|
ADORA1, APP, BCL2, CDC25B, CSNK2A1, DHFR, DRD1, DUSP3, EGFR, ESR1, F3, FABP4, FLT3, GSK3B, HSPA1A, HTR2B, IGF1R, INSR, KDR, MMP9, NUAK1, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
3.41868 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
ADORA1, APP, BCL2, CSNK2A1, DHFR, DUSP3, EGFR, ESR1, ESR2, ESRRA, FABP4, GSK3B, HSPA1A, HTR2B, IGF1R, KDR, MET, MMP12, MMP9, PPARA, PTGS2, PTPN1, SMAD3, SRC, TNKS, TNKS2, XDH |
3.39485 |
[BP] GO:0050678 |
None
|
CDK6, EGFR, F3, HTR2B, KDR, MMP12, SMAD3, TEK, XDH |
3.37848 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
BCL2, CSNK2A1, DRD1, EGFR, FLT3, GSK3B, IGF1R, INSR, KDR, MET, SRC, TEK, TNKS, TOP1 |
3.34645 |
[BP] GO:0001503 |
ossification
|
ALPL, BCL2, EGFR, MMP2, MMP9, TEK |
3.34283 |
[BP] GO:1901699 |
cellular response to nitrogen compound
|
AKR1B1, APP, DRD1, EGFR, GSK3B, IGF1R, INSR, MMP2, PTGS2, SRC |
3.34255 |
[BP] GO:0006807 |
nitrogen compound metabolic process
|
ACHE, AKR1B1, AKR1B10, ALPL, AOX1, APP, BACE1, BCL2, CDC25B, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DRD1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, FUT7, GBA2, GSK3B, HSPA1A, HTR1A, HTR2B, IDO1, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, TOP1, TYR, XDH |
3.32844 |
[BP] GO:0006950 |
response to stress
|
ACHE, ADORA1, ADORA3, AKR1B1, APP, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, DHFR, DRD1, EGFR, GSK3B, HSD11B2, HSPA1A, HTR1A, IDO1, MMP2, MMP9, NUAK1, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK |
3.32171 |
[BP] GO:0051338 |
regulation of transferase activity
|
ADORA1, APP, CDC25B, DUSP3, EGFR, FABP4, FLT3, GSK3B, HTR2B, IGF1R, INSR, PTPN1, SRC, TEK, TNKS |
3.31646 |
[BP] GO:0043405 |
regulation of MAP kinase activity
|
ADORA1, DUSP3, EGFR, FLT3, HTR2B, IGF1R, INSR, PTPN1, SRC |
3.29315 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, APP, BCL2, CYP1B1, EGFR, HSPA1A, MMP9, PTGS2, SRC |
3.26616 |
[BP] GO:0051098 |
regulation of binding
|
APP, BCL2, GSK3B, MET, MMP9, PPARA, SMAD3, SRC, TNKS |
3.26616 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.23863 |
[BP] GO:0051130 |
positive regulation of cellular component organization
|
APP, BCL2, ESR1, GSK3B, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP9, SMAD3, SRC, TEK, TNKS, TNKS2 |
3.23214 |
[BP] GO:0048869 |
cellular developmental process
|
ACHE, ALPL, APP, BCL2, CDC25B, CDK6, CYP1A1, DRD1, EGFR, ESR1, ESRRB, FABP4, FLT3, FUT7, GBA2, GSK3B, HTR2B, KDR, MET, MMP2, MMP9, PTGS2, SMAD3, SRC, TEK |
3.20972 |
[BP] GO:0010810 |
regulation of cell-substrate adhesion
|
BCL2, CDK6, GSK3B, KDR, SMAD3, SRC, TEK |
3.1874 |
[BP] GO:0010907 |
None
|
ESRRB, INSR, PPARA, SRC |
3.18555 |
[BP] GO:0009968 |
negative regulation of signal transduction
|
BCL2, DUSP3, EGFR, ESR1, ESR2, GSK3B, HSPA1A, IGF1R, MET, MMP12, MMP9, PTGS2, PTPN1, SMAD3, SRC, XDH |
3.18274 |
[BP] GO:0009894 |
regulation of catabolic process
|
ADORA1, BCL2, CSNK2A1, EGFR, ESRRB, GSK3B, HSPA1A, HTR2B, INSR, KDR, MET, PPARA, PTPN1, SMAD3 |
3.18017 |
[BP] GO:0050801 |
ion homeostasis
|
APP, BCL2, CA12, CA2, CA7, DRD1, EGFR, ESR1, FABP3, GPR35, HTR2B, SMAD3 |
3.18017 |
[BP] GO:0030155 |
regulation of cell adhesion
|
BCL2, CDK6, CYP1B1, DUSP3, GSK3B, IDO1, KDR, NUAK1, PPARA, SMAD3, SRC, TEK |
3.18017 |
[BP] GO:0032355 |
response to estradiol
|
CYP1A2, EGFR, ESR1, ESRRA, HTR5A, PTGS2 |
3.17346 |
[BP] GO:1903725 |
regulation of phospholipid metabolic process
|
FABP3, FLT3, HTR2B, SRC, TEK |
3.15889 |
[BP] GO:0010634 |
positive regulation of epithelial cell migration
|
KDR, MET, MMP9, PTGS2, SRC, TEK |
3.15697 |
[BP] GO:0007167 |
enzyme linked receptor protein signaling pathway
|
EGFR, FLT3, IGF1R, INSR, KDR, MET, MMP2, MMP9, PTPN1, SMAD3, SRC, TEK |
3.15474 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, AKR1B10, CYP19A1, CYP1A2, CYP1B1, FABP3, FABP4, GBA2 |
3.14531 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CYP19A1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.1424 |
[BP] GO:0009891 |
positive regulation of biosynthetic process
|
APP, DRD1, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, HTR2B, IGF1R, INSR, KDR, MET, MMP12, PPARA, PTGS2, SMAD3, SRC, TNKS, TNKS2 |
3.13761 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, CYP1A1, FABP3, FLT3, HTR2B, PPARA, PTGS2, SRC, TEK |
3.1066 |
[BP] GO:0070372 |
regulation of ERK1 and ERK2 cascade
|
APP, DUSP3, EGFR, HTR2B, KDR, PTPN1, SRC, TEK |
3.1058 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, SRC |
3.0732 |
[BP] GO:0044267 |
cellular protein metabolic process
|
ALPL, APP, BACE1, BCL2, CDC25B, CDK6, CSNK2A1, DRD1, DUSP3, EGFR, ESR1, FLT3, FUT7, GSK3B, HTR2B, IGF1R, INSR, KDR, MET, MMP1, MMP2, NUAK1, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, TOP1 |
3.0732 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, EGFR, MMP2, MMP9, PTGS2 |
3.06085 |
[BP] GO:0032103 |
positive regulation of response to external stimulus
|
EGFR, F3, FABP4, IDO1, KDR, MET, PTGS2, SMAD3 |
3.0556 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, CDK6, CYP1B1, DRD1, EGFR, KDR, PTGS2, SRC |
3.02359 |
[BP] GO:0018958 |
None
|
AKR1B1, BCL2, DRD1, HTR1A, TYR |
3.01372 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADORA1, ADORA3, APP, BCL2, CDC25B, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DRD1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GSK3B, HSPA1A, HTR1A, HTR2B, IGF1R, INSR, KDR, MET, MMP12, MMP9, NUAK1, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, TOP1, XDH |
3.01372 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
APP, BCL2, CA2, CYP1B1, EGFR, ESRRB, F3, HSPA1A, HTR2B, IDO1, KDR, MET, MMP12, MMP9, PTGS2, SMAD3, SRC, TEK |
2.99882 |
[BP] GO:0008285 |
negative regulation of cell proliferation
|
ADORA1, ADORA3, APP, BCL2, CDK6, CYP1B1, FABP3, HSPA1A, IDO1, PTGS2, SMAD3, XDH |
2.99882 |
[BP] GO:0032787 |
None
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, FABP3, GBA2, IDO1, PPARA, PTGS2, TBXAS1 |
2.99109 |
[BP] GO:0043393 |
regulation of protein binding
|
APP, BCL2, GSK3B, MET, MMP9, PPARA, SRC |
2.99109 |
[BP] GO:0043281 |
regulation of cysteine-type endopeptidase activity involved in apoptotic process
|
CSNK2A1, F3, MMP9, PTGS2, SMAD3, SRC, XDH |
2.97903 |
[BP] GO:0009115 |
None
|
AOX1, XDH |
2.93971 |
[BP] GO:0051384 |
response to glucocorticoid
|
ALPL, BCL2, EGFR, FLT3, HSD11B2, PTGS2 |
2.93554 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.93301 |
[BP] GO:0033273 |
response to vitamin
|
ALPL, CYP1A1, EGFR, PTGS2, TYR |
2.9307 |
[BP] GO:0003006 |
developmental process involved in reproduction
|
ALPL, BCL2, CDC25B, CYP19A1, EGFR, ESR1, ESRRB, HSD17B2, INSR, PTGS2, SRC |
2.92934 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
EGFR, F3, INSR, MET, SRC, TEK, XDH |
2.92612 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, FABP3, PPARA, PTGS2, TBXAS1 |
2.9075 |
[BP] GO:0043549 |
regulation of kinase activity
|
ADORA1, APP, CDC25B, DUSP3, EGFR, FABP4, FLT3, HTR2B, IGF1R, INSR, PTPN1, SRC, TEK |
2.90079 |
[BP] GO:1904407 |
positive regulation of nitric oxide metabolic process
|
EGFR, INSR, PTGS2, SMAD3 |
2.87462 |
[BP] GO:0045429 |
positive regulation of nitric oxide biosynthetic process
|
EGFR, INSR, PTGS2, SMAD3 |
2.87462 |
[BP] GO:0032845 |
None
|
ADORA1, BCL2, HTR2B, SRC, TNKS, TNKS2 |
2.8688 |
[BP] GO:0009987 |
cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APP, BACE1, BCL2, CA1, CA12, CA2, CA4, CA6, CA7, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DRD1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GBA2, GPR35, GSK3B, HSD17B1, HSD17B2, HSPA1A, HTR1A, HTR2B, HTR5A, HTR6, HTR7, IDO1, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PPARA, PTGS2, PTPN1, SMAD3, SRC, TBXAS1, TEK, TNKS, TNKS2, TOP1, TYR, XDH |
2.86028 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.85302 |
[BP] GO:0071248 |
cellular response to metal ion
|
CYP1A1, CYP1A2, EGFR, FABP4, MMP9, PTGS2 |
2.80745 |
[BP] GO:1904951 |
positive regulation of establishment of protein localization
|
ACHE, APP, BCL2, EGFR, GSK3B, HTR2B, MMP12, PTGS2, SMAD3, SRC |
2.76028 |
[BP] GO:2000379 |
positive regulation of reactive oxygen species metabolic process
|
EGFR, INSR, PTGS2, SMAD3, XDH |
2.76028 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
CA2, CA7, DRD1, EGFR, PTGS2, TNKS, TNKS2 |
2.75862 |
[BP] GO:0051897 |
positive regulation of protein kinase B signaling
|
EGFR, F3, INSR, MET, SRC, TEK |
2.74949 |
[BP] GO:0031328 |
positive regulation of cellular biosynthetic process
|
APP, DRD1, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, HTR2B, IGF1R, INSR, MET, MMP12, PPARA, PTGS2, SMAD3, SRC, TNKS, TNKS2 |
2.73949 |
[BP] GO:0031324 |
negative regulation of cellular metabolic process
|
APP, BCL2, CSNK2A1, DHFR, DUSP3, ESR1, ESR2, ESRRA, FABP4, GSK3B, HSPA1A, HTR2B, IGF1R, MET, MMP12, MMP9, PPARA, PTGS2, PTPN1, SMAD3, SRC, TNKS, TNKS2, XDH |
2.7368 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, PTGS2, TBXAS1 |
2.70753 |
[BP] GO:0060255 |
regulation of macromolecule metabolic process
|
ACHE, ADORA1, ADORA3, APP, BCL2, CDC25B, CDK6, CSNK2A1, CYP1A2, CYP1B1, DHFR, DRD1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP4, FLT3, GSK3B, HSPA1A, HTR2B, IGF1R, INSR, KDR, MET, MMP12, MMP9, NUAK1, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, TOP1, XDH |
2.70521 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA6, CA7, FABP3, PPARA |
2.69799 |
[BP] GO:0098771 |
inorganic ion homeostasis
|
APP, BCL2, CA12, CA2, CA7, DRD1, EGFR, ESR1, GPR35, HTR2B, SMAD3 |
2.69004 |
[BP] GO:0051701 |
interaction with host
|
EGFR, HSPA1A, INSR, MET, SMAD3, SRC |
2.66795 |
[BP] GO:2001242 |
regulation of intrinsic apoptotic signaling pathway
|
BCL2, HSPA1A, MMP9, PTGS2, PTPN1, SRC |
2.66795 |
[BP] GO:0065007 |
biological regulation
|
ACHE, ADORA1, ADORA3, AKR1B1, APP, BACE1, BCL2, CA1, CA12, CA2, CA7, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DRD1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GPR35, GSK3B, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, HTR1A, HTR2B, HTR5A, HTR6, HTR7, IDO1, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, TOP1, XDH |
2.66546 |
[BP] GO:2000116 |
regulation of cysteine-type endopeptidase activity
|
CSNK2A1, F3, MMP9, PTGS2, SMAD3, SRC, XDH |
2.65736 |
[BP] GO:0010906 |
None
|
ESRRB, GSK3B, INSR, PPARA, SRC |
2.6467 |
[BP] GO:0051336 |
regulation of hydrolase activity
|
APP, CSNK2A1, EGFR, ESR1, F3, GSK3B, HSPA1A, HTR2B, MMP9, NUAK1, PTGS2, PTPN1, SMAD3, SRC, XDH |
2.63614 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, BCL2, CYP1A1, EGFR, ESR1, FLT3, HTR1A, MET, SRC, TEK, TYR |
2.62816 |
[BP] GO:0022900 |
electron transport chain
|
AKR1B1, AOX1, CYP19A1, CYP1A2, IDO1, XDH |
2.61697 |
[BP] GO:0007610 |
None
|
APP, BCL2, DRD1, EGFR, HTR1A, HTR2B, IDO1, INSR, PPARA, PTGS2 |
2.61401 |
[BP] GO:0007346 |
regulation of mitotic cell cycle
|
APP, BCL2, CDC25B, CDK6, CYP1A1, DUSP3, EGFR, HSPA1A, INSR, SMAD3, TNKS |
2.6023 |
[BP] GO:0048732 |
gland development
|
BCL2, CSNK2A1, CYP19A1, EGFR, INSR, SMAD3, TYR |
2.5978 |
[BP] GO:0018105 |
peptidyl-serine phosphorylation
|
BCL2, DRD1, GSK3B, SRC, TNKS, TOP1 |
2.58071 |
[BP] GO:0045859 |
regulation of protein kinase activity
|
ADORA1, APP, CDC25B, DUSP3, EGFR, FABP4, FLT3, HTR2B, IGF1R, INSR, PTPN1, SRC |
2.58024 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, PTGS2, TBXAS1 |
2.5771 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
ADORA1, APP, BCL2, CDC25B, EGFR, FLT3, HTR2B, INSR, KDR, MMP9, PTGS2, PTPN1, SRC, TEK, XDH |
2.56947 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, SRC |
2.55831 |
[BP] GO:0016137 |
None
|
AKR1B1, AKR1B10, GBA2 |
2.55626 |
[BP] GO:0006464 |
cellular protein modification process
|
ALPL, APP, BCL2, CDC25B, CDK6, CSNK2A1, DRD1, DUSP3, EGFR, ESR1, FLT3, FUT7, GSK3B, HTR2B, IGF1R, INSR, KDR, MET, NUAK1, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, TOP1 |
2.54815 |
[BP] GO:0036211 |
protein modification process
|
ALPL, APP, BCL2, CDC25B, CDK6, CSNK2A1, DRD1, DUSP3, EGFR, ESR1, FLT3, FUT7, GSK3B, HTR2B, IGF1R, INSR, KDR, MET, NUAK1, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, TOP1 |
2.54815 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, CSNK2A1, CYP19A1, CYP1A1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, PTGS2 |
2.54769 |
[BP] GO:0072593 |
reactive oxygen species metabolic process
|
BCL2, CYP1A1, CYP1A2, CYP1B1, EGFR |
2.54769 |
[BP] GO:0046110 |
None
|
AOX1, XDH |
2.54769 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.54769 |
[BP] GO:1903428 |
positive regulation of reactive oxygen species biosynthetic process
|
EGFR, INSR, PTGS2, SMAD3 |
2.52881 |
[BP] GO:0010676 |
None
|
ESRRB, INSR, PPARA, SRC |
2.52881 |
[BP] GO:0031348 |
negative regulation of defense response
|
ADORA1, CYP19A1, MMP12, PPARA, SMAD3, TEK |
2.51567 |
[BP] GO:0071241 |
cellular response to inorganic substance
|
CYP1A1, CYP1A2, EGFR, FABP4, MMP9, PTGS2 |
2.50418 |
[BP] GO:0051900 |
regulation of mitochondrial depolarization
|
BCL2, KDR, SRC |
2.50021 |
[BP] GO:0051704 |
multi-organism process
|
APP, BCL2, CDK6, CYP1A1, EGFR, HSD11B2, HSPA1A, IDO1, INSR, KDR, MET, MMP1, MMP12, SMAD3, SRC, TOP1 |
2.49132 |
[BP] GO:0003008 |
None
|
ADORA1, AKR1B1, APP, BCL2, CYP1B1, DRD1, EGFR, HSD11B2, HTR1A, HTR2B, HTR7, INSR, PTGS2, SRC, TEK, TYR |
2.49017 |
[BP] GO:0090087 |
None
|
ACHE, ADORA1, APP, CA2, EGFR, GSK3B, HTR2B, MMP12, PTGS2, PTPN1, SMAD3, SRC |
2.48915 |
[BP] GO:0010811 |
positive regulation of cell-substrate adhesion
|
CDK6, GSK3B, KDR, SMAD3, TEK |
2.4853 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, BCL2, CYP1B1, EGFR, MMP9, SRC |
2.4853 |
[BP] GO:0051893 |
regulation of focal adhesion assembly
|
KDR, SMAD3, SRC, TEK |
2.48205 |
[BP] GO:0033555 |
multicellular organismal response to stress
|
BCL2, DRD1, HTR1A, IDO1 |
2.48205 |
[BP] GO:0090109 |
regulation of cell-substrate junction assembly
|
KDR, SMAD3, SRC, TEK |
2.48205 |
[BP] GO:0050679 |
None
|
EGFR, F3, HTR2B, KDR, MMP12, TEK |
2.47784 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, SRC |
2.47784 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, EGFR |
2.47417 |
[BP] GO:1901575 |
None
|
ACHE, ADORA1, AKR1B10, AOX1, BACE1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, FUT7, GBA2, GSK3B, HSPA1A, IDO1, XDH |
2.4667 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, CYP1B1, EGFR, MMP9, SRC |
2.45738 |
[BP] GO:0045935 |
positive regulation of nucleobase-containing compound metabolic process
|
APP, DRD1, EGFR, ESR1, ESR2, ESRRA, ESRRB, HSPA1A, IGF1R, INSR, MET, MMP12, PPARA, PTPN1, SMAD3, SRC, TNKS, TNKS2 |
2.45615 |
[BP] GO:0009895 |
negative regulation of catabolic process
|
ADORA1, BCL2, EGFR, HTR2B, MET, PPARA, SMAD3 |
2.42066 |
[BP] GO:0043406 |
positive regulation of MAP kinase activity
|
ADORA1, EGFR, FLT3, HTR2B, INSR, PTPN1, SRC |
2.41402 |
[BP] GO:1903391 |
regulation of adherens junction organization
|
KDR, SMAD3, SRC, TEK |
2.40548 |
[BP] GO:0045428 |
regulation of nitric oxide biosynthetic process
|
EGFR, INSR, PTGS2, SMAD3 |
2.40548 |
[BP] GO:0097164 |
None
|
ACHE, AKR1B1, AKR1B10, CSNK2A1, DRD1, HTR1A |
2.3991 |
[BP] GO:0016477 |
cell migration
|
CYP1B1, DRD1, EGFR, FUT7, HTR2B, HTR6, KDR, MMP1, MMP12, MMP9, SRC, TEK |
2.3991 |
[BP] GO:0071498 |
cellular response to fluid shear stress
|
CA2, PTGS2, SRC |
2.3991 |
[BP] GO:0051968 |
None
|
DRD1, EGFR, PTGS2 |
2.3991 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
2.3991 |
[BP] GO:0050793 |
regulation of developmental process
|
APP, BCL2, CA2, CDK6, CYP1B1, EGFR, ESR1, ESRRA, ESRRB, F3, GSK3B, IDO1, INSR, KDR, NUAK1, PPARA, PTGS2, SMAD3, SRC, TEK, TNKS2, XDH |
2.39873 |
[BP] GO:0007187 |
None
|
ADORA1, DRD1, HTR1A, HTR5A, HTR6, HTR7 |
2.39229 |
[BP] GO:0018209 |
peptidyl-serine modification
|
BCL2, DRD1, GSK3B, SRC, TNKS, TOP1 |
2.38038 |
[BP] GO:0051966 |
regulation of synaptic transmission, glutamatergic
|
ADORA1, DRD1, EGFR, PTGS2 |
2.35737 |
[BP] GO:0080090 |
regulation of primary metabolic process
|
ADORA1, ADORA3, APP, BCL2, CDC25B, CSNK2A1, CYP1A1, CYP1B1, DHFR, DRD1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GSK3B, HSPA1A, HTR1A, HTR2B, IGF1R, INSR, KDR, MET, MMP12, MMP9, NUAK1, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
2.35222 |
[BP] GO:0050728 |
negative regulation of inflammatory response
|
ADORA1, CYP19A1, PPARA, SMAD3, TEK |
2.35067 |
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.34502 |
[BP] GO:0051222 |
positive regulation of protein transport
|
ACHE, APP, EGFR, GSK3B, HTR2B, MMP12, PTGS2, SMAD3, SRC |
2.3187 |
[BP] GO:0007186 |
G-protein coupled receptor signaling pathway
|
ADORA1, ADORA3, APP, CA2, DRD1, ESR1, GPR35, GSK3B, HTR1A, HTR2B, HTR5A, HTR6, HTR7, INSR, SRC |
2.31805 |
[BP] GO:0070213 |
None
|
TNKS, TNKS2 |
2.30772 |
[BP] GO:0006145 |
None
|
AOX1, XDH |
2.30772 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.30772 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, DHFR, FABP3, GBA2, IDO1, PPARA, PTGS2, TBXAS1, TYR |
2.30229 |
[BP] GO:0043434 |
None
|
FABP3, HSD11B2, INSR, PPARA, PTGS2, SRC, TEK |
2.30091 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.29733 |
[BP] GO:0031323 |
regulation of cellular metabolic process
|
ACHE, ADORA1, ADORA3, APP, BCL2, CDC25B, CSNK2A1, CYP1B1, DHFR, DRD1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GSK3B, HSPA1A, HTR1A, HTR2B, IGF1R, INSR, KDR, MET, MMP12, MMP9, NUAK1, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
2.29733 |
[BP] GO:0044089 |
positive regulation of cellular component biogenesis
|
ESR1, GSK3B, HSPA1A, KDR, MET, MMP1, SMAD3, SRC, TEK |
2.29733 |
[BP] GO:0043065 |
positive regulation of apoptotic process
|
BCL2, CYP1B1, F3, GSK3B, IDO1, MMP9, PTGS2, SMAD3, SRC, XDH |
2.27463 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, CYP1B1, EGFR, HSPA1A, MMP9, SRC |
2.27463 |
[BP] GO:2001233 |
regulation of apoptotic signaling pathway
|
BCL2, GSK3B, HSPA1A, MMP9, PTGS2, PTPN1, SMAD3, SRC |
2.27139 |
[BP] GO:0043269 |
regulation of ion transport
|
ADORA1, APP, BCL2, CA2, CA7, DRD1, GPR35, HTR1A, MMP9, PTGS2 |
2.27139 |
[BP] GO:0002009 |
morphogenesis of an epithelium
|
BCL2, CA2, EGFR, ESR1, MET, SMAD3, SRC |
2.27139 |
[BP] GO:0010675 |
None
|
ESRRB, GSK3B, INSR, PPARA, SRC |
2.27029 |
[BP] GO:0051894 |
None
|
KDR, SMAD3, TEK |
2.25522 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.25522 |
[BP] GO:0043068 |
positive regulation of programmed cell death
|
BCL2, CYP1B1, F3, GSK3B, IDO1, MMP9, PTGS2, SMAD3, SRC, XDH |
2.25153 |
[BP] GO:0050805 |
negative regulation of synaptic transmission
|
ACHE, ADORA1, DRD1, PTGS2 |
2.25153 |
[BP] GO:0070374 |
positive regulation of ERK1 and ERK2 cascade
|
APP, EGFR, HTR2B, KDR, SRC, TEK |
2.25153 |
[BP] GO:0051726 |
regulation of cell cycle
|
APP, BCL2, CDC25B, CDK6, CSNK2A1, CYP1A1, DUSP3, EGFR, HSPA1A, INSR, PTGS2, SMAD3, SRC, TNKS |
2.23024 |
[BP] GO:0030574 |
collagen catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.228 |
[BP] GO:0010605 |
negative regulation of macromolecule metabolic process
|
APP, CSNK2A1, DHFR, DUSP3, EGFR, ESR1, ESR2, ESRRA, FABP4, GSK3B, HSPA1A, IGF1R, KDR, MMP12, MMP9, PPARA, PTGS2, PTPN1, SMAD3, SRC, TNKS, TNKS2, XDH |
2.22261 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, EGFR |
2.215 |
[BP] GO:0040011 |
locomotion
|
CYP1B1, DRD1, EGFR, FUT7, HTR2B, HTR6, KDR, MET, MMP1, MMP12, MMP9, SRC, TEK |
2.215 |
[BP] GO:0051171 |
regulation of nitrogen compound metabolic process
|
ADORA1, ADORA3, APP, BCL2, CDC25B, CSNK2A1, CYP1B1, DHFR, DRD1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GSK3B, HSPA1A, HTR1A, HTR2B, IGF1R, INSR, KDR, MET, MMP12, MMP9, NUAK1, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
2.21194 |
[BP] GO:0050927 |
None
|
F3, KDR, SMAD3 |
2.21194 |
[BP] GO:0071900 |
regulation of protein serine/threonine kinase activity
|
ADORA1, DUSP3, EGFR, FLT3, HTR2B, IGF1R, INSR, PTPN1, SRC |
2.20866 |
[BP] GO:0001819 |
positive regulation of cytokine production
|
CYP1B1, HSPA1A, HTR2B, IDO1, MMP12, PTGS2, SMAD3, SRC |
2.18481 |
[BP] GO:0055080 |
cation homeostasis
|
APP, BCL2, CA2, CA7, DRD1, EGFR, ESR1, GPR35, HTR2B, SMAD3 |
2.17832 |
[BP] GO:0048660 |
regulation of smooth muscle cell proliferation
|
AKR1B1, EGFR, MMP2, MMP9, PTGS2 |
2.17381 |
[BP] GO:0050926 |
None
|
F3, KDR, SMAD3 |
2.16958 |
[BP] GO:0005979 |
None
|
ESRRB, GSK3B, INSR |
2.16958 |
[BP] GO:1903393 |
None
|
KDR, SMAD3, TEK |
2.16958 |
[BP] GO:0010962 |
None
|
ESRRB, GSK3B, INSR |
2.16958 |
[BP] GO:0045913 |
None
|
ESRRB, INSR, PPARA, SRC |
2.16776 |
[BP] GO:0052548 |
None
|
APP, CSNK2A1, F3, MMP9, PTGS2, SMAD3, SRC, XDH |
2.16437 |
[BP] GO:1900182 |
positive regulation of protein localization to nucleus
|
APP, EGFR, PTGS2, SMAD3, SRC |
2.15176 |
[BP] GO:0042180 |
None
|
AKR1B1, AKR1B10, CYP19A1, IDO1 |
2.1473 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, BCL2, CYP1A1, CYP1B1, DRD1, KDR, SRC |
2.14716 |
[BP] GO:1901653 |
cellular response to peptide
|
AKR1B1, APP, GSK3B, IGF1R, INSR, SRC |
2.14716 |
[BP] GO:0043696 |
None
|
CDK6, ESRRB |
2.13861 |
[BP] GO:0043697 |
None
|
CDK6, ESRRB |
2.13861 |
[BP] GO:0010641 |
None
|
F3, SRC |
2.13861 |
[BP] GO:1904357 |
None
|
SRC, TNKS, TNKS2 |
2.13532 |
[BP] GO:1904646 |
cellular response to amyloid-beta
|
APP, GSK3B, IGF1R |
2.13532 |
[BP] GO:0031667 |
response to nutrient levels
|
ALPL, BCL2, CYP1A1, EGFR, HSD11B2, PTGS2, SRC, TYR |
2.1345 |
[BP] GO:2001234 |
negative regulation of apoptotic signaling pathway
|
BCL2, HSPA1A, MMP9, PTGS2, PTPN1, SRC |
2.12362 |
[BP] GO:0001936 |
None
|
F3, HTR2B, KDR, TEK, XDH |
2.1198 |
[BP] GO:0051054 |
positive regulation of DNA metabolic process
|
EGFR, IGF1R, INSR, SRC, TNKS, TNKS2 |
2.10336 |
[BP] GO:0035556 |
intracellular signal transduction
|
AKR1B1, BCL2, CYP1B1, DRD1, EGFR, GSK3B, HTR2B, HTR5A, IGF1R, INSR, KDR, MET, NUAK1, PTPN1, SRC, TEK |
2.10175 |
[BP] GO:0002682 |
regulation of immune system process
|
ADORA1, APP, BCL2, CA2, CDK6, CYP19A1, DUSP3, ESR1, ESRRA, HSPA1A, IDO1, MMP12, MMP2, PTPN1, SMAD3, SRC |
2.09948 |
[BP] GO:0048870 |
cell motility
|
CYP1B1, DRD1, EGFR, FUT7, HTR2B, HTR6, KDR, MMP1, MMP12, MMP9, SRC, TEK |
2.09209 |
[BP] GO:0030198 |
extracellular matrix organization
|
APP, CYP1B1, KDR, MMP1, MMP12, MMP2, MMP9 |
2.08837 |
[BP] GO:0035239 |
tube morphogenesis
|
BCL2, EGFR, ESR1, MET, SMAD3, SRC |
2.08837 |
[BP] GO:0010632 |
regulation of epithelial cell migration
|
KDR, MET, MMP9, PTGS2, SRC, TEK |
2.08837 |
[BP] GO:0032872 |
regulation of stress-activated MAPK cascade
|
APP, DUSP3, EGFR, IGF1R, PTPN1, XDH |
2.08837 |
[BP] GO:0031099 |
regeneration
|
BCL2, CSNK2A1, DHFR, EGFR, FLT3 |
2.08454 |
[BP] GO:0007623 |
circadian rhythm
|
EGFR, GSK3B, HTR7, PPARA, TOP1 |
2.08454 |
[BP] GO:0043062 |
extracellular structure organization
|
APP, CYP1B1, KDR, MMP1, MMP12, MMP2, MMP9 |
2.08304 |
[BP] GO:0070302 |
regulation of stress-activated protein kinase signaling cascade
|
APP, DUSP3, EGFR, IGF1R, PTPN1, XDH |
2.08142 |
[BP] GO:0044243 |
multicellular organismal catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.07878 |
[BP] GO:0033280 |
response to vitamin D
|
ALPL, PTGS2, TYR |
2.05981 |
[BP] GO:0042310 |
None
|
HTR1A, HTR2B, HTR7 |
2.05981 |
[BP] GO:0031349 |
positive regulation of defense response
|
EGFR, FABP4, HSPA1A, IDO1, MMP12, MMP2, PTGS2, SRC |
2.05981 |
[BP] GO:0072507 |
divalent inorganic cation homeostasis
|
APP, BCL2, DRD1, EGFR, ESR1, GPR35, HTR2B, SMAD3 |
2.05981 |
[BP] GO:0032868 |
None
|
FABP3, HSD11B2, INSR, PPARA, SRC |
2.04818 |
[BP] GO:0010942 |
positive regulation of cell death
|
BCL2, CYP1B1, F3, GSK3B, IDO1, MMP9, PTGS2, SMAD3, SRC, XDH |
2.04199 |
[BP] GO:1900180 |
regulation of protein localization to nucleus
|
APP, EGFR, GSK3B, PTGS2, SMAD3, SRC |
2.03541 |
[BP] GO:0043271 |
negative regulation of ion transport
|
ADORA1, BCL2, GPR35, MMP9, PTGS2 |
2.02724 |
[BP] GO:0035265 |
organ growth
|
BCL2, CYP19A1, ESR1 |
2.02724 |
[BP] GO:0002209 |
None
|
BCL2, DRD1, HTR1A |
2.02724 |
[BP] GO:0001662 |
None
|
BCL2, DRD1, HTR1A |
2.02724 |
[BP] GO:0070873 |
None
|
ESRRB, GSK3B, INSR |
2.02724 |
[BP] GO:0043552 |
positive regulation of phosphatidylinositol 3-kinase activity
|
FLT3, SRC, TEK |
2.02724 |
[BP] GO:0042743 |
hydrogen peroxide metabolic process
|
CYP1A1, CYP1A2, EGFR |
2.02724 |
[BP] GO:1904645 |
response to amyloid-beta
|
APP, GSK3B, IGF1R |
2.02724 |
[BP] GO:0007193 |
None
|
ADORA1, HTR1A, HTR5A, HTR7 |
2.02666 |
[BP] GO:2000026 |
regulation of multicellular organismal development
|
APP, BCL2, CA2, CDK6, CYP1B1, EGFR, ESR1, ESRRA, F3, GSK3B, IDO1, INSR, KDR, PTGS2, SMAD3, SRC, TEK, XDH |
2.02259 |
[BP] GO:0052547 |
None
|
APP, CSNK2A1, F3, MMP9, PTGS2, SMAD3, SRC, XDH |
2.01736 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA4, CA6, CA7, FABP3, PPARA |
2.00789 |
[BP] GO:0031334 |
positive regulation of protein complex assembly
|
ESR1, GSK3B, HSPA1A, MET, MMP1, SRC |
2.00789 |
[BP] GO:0051902 |
negative regulation of mitochondrial depolarization
|
BCL2, SRC |
2.00789 |
[BP] GO:0046113 |
None
|
AOX1, XDH |
2.00789 |
[BP] GO:1990535 |
None
|
APP, INSR |
2.00789 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADORA1, ADORA3, APP, BACE1, CA4, DRD1, F3, FLT3, GPR35, HTR1A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, TEK |
3.73151 |
[CC] GO:0044432 |
endoplasmic reticulum part
|
APP, BACE1, BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, EGFR, FLT3, GBA2, HSD11B1, HSD11B2, HSD17B2, PTGS2, PTPN1, TBXAS1 |
3.3227 |
[CC] GO:0016020 |
membrane
|
ACHE, ADORA1, ADORA3, ALOX5, ALPL, APP, BACE1, BCL2, CA12, CA14, CA2, CA4, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, EGFR, ESR1, F3, FLT3, FUT7, GBA2, GPR35, GSK3B, HSD11B1, HSD11B2, HSD17B2, HTR1A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, MMP2, PTGS2, PTPN1, SMAD3, SRC, TBXAS1, TEK, TNKS, TNKS2, TYR |
2.99879 |
[CC] GO:0045121 |
membrane raft
|
APP, BACE1, EGFR, INSR, KDR, PTGS2, SRC, TEK |
2.9307 |
[CC] GO:0005887 |
integral component of plasma membrane
|
ADORA1, ADORA3, APP, BACE1, DRD1, FLT3, GPR35, HTR1A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, TEK |
2.92612 |
[CC] GO:0098857 |
membrane microdomain
|
APP, BACE1, EGFR, INSR, KDR, PTGS2, SRC, TEK |
2.91652 |
[CC] GO:0005886 |
plasma membrane
|
ACHE, ADORA1, ADORA3, ALPL, APP, BACE1, CA12, CA14, CA2, CA4, CSNK2A1, DRD1, EGFR, ESR1, F3, FLT3, GBA2, GPR35, GSK3B, HTR1A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, MMP2, PTPN1, SMAD3, SRC, TEK |
2.66057 |
[CC] GO:0005789 |
endoplasmic reticulum membrane
|
BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, EGFR, GBA2, HSD11B1, HSD11B2, HSD17B2, PTGS2, TBXAS1 |
2.59197 |
[CC] GO:0044459 |
plasma membrane part
|
ADORA1, ADORA3, APP, BACE1, CA2, CA4, DRD1, DUSP3, EGFR, F3, FLT3, GPR35, HTR1A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, PTGS2, SRC, TEK |
2.51712 |
[CC] GO:0005783 |
None
|
ADORA1, APP, BCL2, CA4, CYP19A1, FLT3, GBA2, HSPA1A, HTR5A, KDR, PTGS2, PTPN1, XDH |
2.50593 |
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, AOX1, APP, BACE1, BCL2, CA1, CA2, CA4, CA7, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DRD1, DUSP3, EGFR, ESR1, ESR2, FABP3, FABP4, FLT3, FUT7, GBA2, GSK3B, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, HTR5A, IDO1, INSR, KDR, MMP2, MMP9, PTGS2, PTPN1, SMAD3, SRC, TBXAS1, TNKS, TNKS2, TOP1, TYR, XDH |
2.49017 |
[CC] GO:0098589 |
membrane region
|
APP, BACE1, EGFR, INSR, KDR, PTGS2, SRC, TEK |
2.454 |
[CC] GO:0044425 |
membrane part
|
ACHE, ADORA1, ADORA3, ALPL, APP, BACE1, BCL2, CA12, CA14, CA2, CA4, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DUSP3, EGFR, ESR1, F3, FLT3, FUT7, GBA2, GPR35, HSD11B1, HSD11B2, HSD17B2, HTR1A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, PTGS2, PTPN1, SRC, TBXAS1, TEK, TYR |
2.41402 |
[CC] GO:0097443 |
sorting endosome
|
KDR, PTPN1 |
2.00789 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX5, AOX1, APP, CA1, CA12, CA2, CA4, CA6, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP12, MMP2, MMP9, PPARA, PTPN1, SMAD3, TBXAS1, TNKS, TYR, XDH |
12.1698 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX5, ALPL, AOX1, APP, CA1, CA12, CA14, CA2, CA4, CA6, CA7, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DRD1, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GSK3B, HSD17B1, HSPA1A, HTR1A, HTR2B, HTR5A, HTR7, IDO1, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PPARA, PTGS2, PTPN1, SMAD3, SRC, TBXAS1, TEK, TNKS, TNKS2, TOP1, TYR, XDH |
12.1698 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, BACE1, CA1, CA12, CA14, CA2, CA4, CA6, CA7, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DUSP3, EGFR, F3, FLT3, FUT7, GBA2, GSK3B, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PTGS2, PTPN1, SRC, TBXAS1, TEK, TNKS, TNKS2, TOP1, TYR, XDH |
10.7581 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA6, CA7 |
9.9918 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IDO1, PTGS2, TBXAS1, TYR, XDH |
6.97039 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX5, ALPL, AOX1, APP, CA1, CA12, CA14, CA2, CA4, CA6, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, ESR1, ESR2, ESRRA, ESRRB, HTR1A, HTR2B, HTR5A, HTR7, IDO1, MMP1, MMP12, MMP2, MMP9, NUAK1, PPARA, PTGS2, PTPN1, SMAD3, TBXAS1, TNKS, TNKS2, TYR, XDH |
6.42026 |
[MF] GO:0008270 |
zinc ion binding
|
CA1, CA12, CA2, CA4, CA6, CA7, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP12, MMP2, MMP9, PPARA, PTPN1, SMAD3, TNKS |
6.38662 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA6, CA7 |
6.22271 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
EGFR, FLT3, IGF1R, INSR, KDR, MET, TEK |
5.94456 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, DRD1, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPR35, HTR1A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, PPARA, TEK |
5.91706 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, CDK6, DRD1, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPR35, HTR1A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, PPARA, TEK |
5.45578 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA6, CA7 |
5.41433 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
EGFR, FLT3, IGF1R, INSR, KDR, MET, TEK |
5.29955 |
[MF] GO:0004993 |
None
|
HTR1A, HTR2B, HTR5A, HTR6, HTR7 |
5.19514 |
[MF] GO:0099589 |
None
|
HTR1A, HTR2B, HTR5A, HTR6, HTR7 |
5.19514 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, IDO1, PTGS2, SRC, TBXAS1 |
5.18844 |
[MF] GO:0048037 |
cofactor binding
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, HSD11B2, HSD17B1, IDO1, PTGS2, SRC, TBXAS1, XDH |
5.18844 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, DRD1, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPR35, HTR1A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, PPARA, TEK |
5.11219 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, DRD1, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPR35, HTR1A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, PPARA, SMAD3, TEK |
5.05394 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, AOX1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, XDH |
5.01885 |
[MF] GO:0008144 |
drug binding
|
ACHE, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DRD1, EGFR, FLT3, GSK3B, HSPA1A, HTR2B, IGF1R, INSR, KDR, MET, NUAK1, PPARA, SRC, TEK, TOP1 |
5.00974 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, IDO1, PTGS2, SRC, TBXAS1 |
4.98968 |
[MF] GO:0043176 |
None
|
HTR1A, HTR2B, HTR5A, HTR7 |
4.92797 |
[MF] GO:0051378 |
None
|
HTR1A, HTR2B, HTR5A, HTR7 |
4.92797 |
[MF] GO:0005506 |
iron ion binding
|
ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, TBXAS1, XDH |
4.54885 |
[MF] GO:0099528 |
None
|
HTR1A, HTR2B, HTR5A, HTR6, HTR7 |
4.29425 |
[MF] GO:0070405 |
ammonium ion binding
|
ACHE, DRD1, HTR1A, HTR2B, HTR5A, HTR7 |
4.26499 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
4.19218 |
[MF] GO:0005496 |
steroid binding
|
ESR1, ESR2, ESRRA, ESRRB, HSD11B2, HSD17B1 |
3.93485 |
[MF] GO:0004672 |
protein kinase activity
|
CDK6, CSNK2A1, EGFR, FLT3, GSK3B, IGF1R, INSR, KDR, MET, NUAK1, SRC, TEK, TOP1 |
3.9234 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
ESR1, ESR2, ESRRA, ESRRB, PPARA |
3.83921 |
[MF] GO:0004879 |
nuclear receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA |
3.83921 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, ADORA1, EGFR, ESRRB, FLT3, IGF1R, INSR, KDR, MMP12, MMP9, PPARA, PTPN1, SMAD3, SRC |
3.76008 |
[MF] GO:0042165 |
neurotransmitter binding
|
ACHE, HTR1A, HTR2B, HTR5A, HTR7 |
3.72864 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.72007 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, TBXAS1, TYR |
3.72007 |
[MF] GO:0046872 |
metal ion binding
|
ALOX5, ALPL, AOX1, APP, CA1, CA12, CA14, CA2, CA4, CA6, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, IDO1, MMP1, MMP12, MMP2, MMP9, NUAK1, PPARA, PTGS2, PTPN1, SMAD3, TBXAS1, TNKS, TNKS2, TYR, XDH |
3.6628 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, PTGS2, TBXAS1, TYR |
3.64957 |
[MF] GO:0008227 |
None
|
HTR1A, HTR2B, HTR5A, HTR6, HTR7 |
3.56548 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.53914 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA |
3.50806 |
[MF] GO:0033764 |
steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.47945 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA1, ADORA3, DRD1, EGFR, F3, FLT3, GPR35, HTR1A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, TEK |
3.46933 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA1, ADORA3, DRD1, EGFR, F3, FLT3, GPR35, HTR1A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, TEK |
3.46933 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, AOX1, CYP19A1, CYP1A2, IDO1, XDH |
3.45688 |
[MF] GO:0030594 |
None
|
DRD1, HTR1A, HTR2B, HTR5A, HTR6, HTR7 |
3.43792 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADORA1, CSNK2A1, EGFR, ESRRB, FLT3, IGF1R, INSR, KDR, MMP12, MMP9, PPARA, PTPN1, SMAD3, SRC |
3.43792 |
[MF] GO:0016229 |
steroid dehydrogenase activity
|
HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.37839 |
[MF] GO:0004716 |
signal transducer, downstream of receptor, with protein tyrosine kinase activity
|
EGFR, INSR, KDR |
3.36708 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, AKR1B10, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.25245 |
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA6, CA7 |
3.23863 |
[MF] GO:0097159 |
organic cyclic compound binding
|
ADORA1, AOX1, APP, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DRD1, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GSK3B, HSD11B2, HSD17B1, HSPA1A, HTR1A, HTR2B, HTR5A, HTR7, IDO1, IGF1R, INSR, KDR, MET, MMP12, NUAK1, PPARA, PTGS2, PTPN1, SMAD3, SRC, TBXAS1, TEK, TOP1, XDH |
3.22752 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
CDK6, CSNK2A1, EGFR, FLT3, GSK3B, IGF1R, INSR, KDR, MET, NUAK1, SRC, TEK, TOP1 |
3.1958 |
[MF] GO:0019899 |
enzyme binding
|
APP, BACE1, BCL2, CDC25B, CYP1A1, CYP1A2, DUSP3, EGFR, ESR1, ESR2, ESRRB, F3, GSK3B, HSPA1A, MET, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TNKS2 |
3.01422 |
[MF] GO:1901363 |
heterocyclic compound binding
|
ADORA1, AOX1, APP, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GSK3B, HSD11B2, HSD17B1, HSPA1A, HTR1A, HTR2B, HTR5A, HTR7, IDO1, IGF1R, INSR, KDR, MET, MMP12, NUAK1, PPARA, PTGS2, PTPN1, SMAD3, SRC, TBXAS1, TEK, TOP1, XDH |
2.99882 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
2.93971 |
[MF] GO:0003845 |
None
|
HSD11B1, HSD11B2 |
2.93971 |
[MF] GO:0042562 |
hormone binding
|
ACHE, EGFR, HSD17B1, IGF1R, INSR |
2.8688 |
[MF] GO:0016301 |
kinase activity
|
CDK6, CSNK2A1, EGFR, FLT3, GSK3B, IGF1R, INSR, KDR, MET, NUAK1, SRC, TEK, TOP1 |
2.86567 |
[MF] GO:0016903 |
None
|
AKR1B1, AKR1B10, AOX1, XDH |
2.76184 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
2.73315 |
[MF] GO:0019902 |
phosphatase binding
|
BCL2, EGFR, MET, PPARA, PTPN1, SMAD3 |
2.59271 |
[MF] GO:0140096 |
catalytic activity, acting on a protein
|
BACE1, CDC25B, CDK6, CSNK2A1, DUSP3, EGFR, F3, FLT3, GSK3B, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PTPN1, SRC, TEK, TOP1 |
2.5771 |
[MF] GO:0036094 |
small molecule binding
|
ADORA1, AOX1, CDK6, CSNK2A1, DHFR, EGFR, FABP3, FABP4, FLT3, GSK3B, HSD11B2, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, SRC, TEK, TOP1, XDH |
2.41891 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.30772 |
[MF] GO:0051425 |
None
|
APP, INSR |
2.30772 |
[MF] GO:0005518 |
collagen binding
|
ACHE, MMP12, MMP9, SMAD3 |
2.27043 |
[MF] GO:0042802 |
identical protein binding
|
ACHE, AOX1, APP, BCL2, CSNK2A1, EGFR, ESR1, ESR2, FLT3, IGF1R, KDR, MET, MMP9, PTGS2, SMAD3, TYR, XDH |
2.27043 |
[MF] GO:0016772 |
transferase activity, transferring phosphorus-containing groups
|
CDK6, CSNK2A1, EGFR, FLT3, GSK3B, IGF1R, INSR, KDR, MET, NUAK1, SRC, TEK, TOP1 |
2.25942 |
[MF] GO:0016702 |
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen
|
ALOX5, IDO1, PTGS2 |
2.16958 |
[MF] GO:0019838 |
growth factor binding
|
EGFR, IGF1R, INSR, KDR, TEK |
2.15176 |
[MF] GO:0030284 |
estrogen receptor activity
|
ESR1, ESR2 |
2.13861 |
[MF] GO:0043559 |
insulin binding
|
IGF1R, INSR |
2.13861 |
[MF] GO:0016701 |
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen
|
ALOX5, IDO1, PTGS2 |
2.13532 |
[MF] GO:0004064 |
arylesterase activity
|
CA1, CA2 |
2.00789 |
[MF] GO:0043546 |
None
|
AOX1, XDH |
2.00789 |